These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 30240518)

  • 1. Glial mechanisms underlying substance use disorders.
    Linker KE; Cross SJ; Leslie FM
    Eur J Neurosci; 2019 Aug; 50(3):2574-2589. PubMed ID: 30240518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.
    Lacagnina MJ; Rivera PD; Bilbo SD
    Neuropsychopharmacology; 2017 Jan; 42(1):156-177. PubMed ID: 27402494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial and neuroinflammatory targets for treating substance use disorders.
    Bachtell RK; Jones JD; Heinzerling KG; Beardsley PM; Comer SD
    Drug Alcohol Depend; 2017 Nov; 180():156-170. PubMed ID: 28892721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial neuroimmune signaling in opioid reward.
    Zhang H; Largent-Milnes TM; Vanderah TW
    Brain Res Bull; 2020 Feb; 155():102-111. PubMed ID: 31790721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance Use and Addiction.
    Newton K; De Biase L
    Adv Neurobiol; 2024; 37():343-355. PubMed ID: 39207701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glial cells in drug abuse.
    Miguel-Hidalgo JJ
    Curr Drug Abuse Rev; 2009 Jan; 2(1):72-82. PubMed ID: 19630738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation.
    Dambach H; Hinkerohe D; Prochnow N; Stienen MN; Moinfar Z; Haase CG; Hufnagel A; Faustmann PM
    Epilepsia; 2014 Jan; 55(1):184-92. PubMed ID: 24299259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial modulators as potential treatments of psychostimulant abuse.
    Beardsley PM; Hauser KF
    Adv Pharmacol; 2014; 69():1-69. PubMed ID: 24484974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate drug use and the pathophysiology of neuroAIDS.
    Hauser KF; Fitting S; Dever SM; Podhaizer EM; Knapp PE
    Curr HIV Res; 2012 Jul; 10(5):435-52. PubMed ID: 22591368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Tools to Study the Role of Astrocytes in Neural Network Functions.
    Peña-Ortega F; Rivera-Angulo AJ; Lorea-Hernández JJ
    Adv Exp Med Biol; 2016; 949():47-66. PubMed ID: 27714684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4.
    Bachtell R; Hutchinson MR; Wang X; Rice KC; Maier SF; Watkins LR
    CNS Neurol Disord Drug Targets; 2015; 14(6):692-9. PubMed ID: 26022268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of Glial Cell Modulators in the Management of Substance Use Disorders.
    Jones JD
    CNS Drugs; 2020 Jul; 34(7):697-722. PubMed ID: 32246400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain.
    Donnelly CR; Andriessen AS; Chen G; Wang K; Jiang C; Maixner W; Ji RR
    Neurotherapeutics; 2020 Jul; 17(3):846-860. PubMed ID: 32820378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS.
    Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH
    Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of Fc gamma receptor I and Toll-like receptor 4 mediate the antiinflammatory actions of microglia and astrocytes after adrenaline-induced blood-brain barrier opening in rats.
    Li YN; Qin XJ; Kuang F; Wu R; Duan XL; Ju G; Wang BR
    J Neurosci Res; 2008 Dec; 86(16):3556-65. PubMed ID: 18756515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N; Swaab DF; Hoek RM; Huitinga I
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse?
    Haydon PG; Blendy J; Moss SJ; Rob Jackson F
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):83-90. PubMed ID: 18647612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mixed glial cultures from fetal ovine forebrain are a valid model of inflammation-mediated white matter injury.
    Weaver-Mikaere L; Gibbons HM; De Silva D; Fraser M
    Dev Neurosci; 2012; 34(1):30-42. PubMed ID: 22627272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial regulation of synaptic function in models of addiction.
    Stellwagen D; Kemp GM; Valade S; Chambon J
    Curr Opin Neurobiol; 2019 Aug; 57():179-185. PubMed ID: 31163290
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.